These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26854315)

  • 1. A Brief Clinical Update on Hepatitis C--The Essentials.
    Lee J; Conniff J; Kraus C; Schrager S
    WMJ; 2015 Dec; 114(6):263-9; quiz 270. PubMed ID: 26854315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic trends in infection, mortality, and transplants related to hepatitis C in Wisconsin.
    Gasiorowicz M; Hurie M; Russell A; Hoxie N; Vergeront J
    WMJ; 2006 Jan; 105(1):34-9. PubMed ID: 16676489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hepatitis C infection among patients with renal failure.
    Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A
    Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
    Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
    J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus and nonliver solid organ transplantation.
    Carbone M; Mutimer D; Neuberger J
    Transplantation; 2013 Mar; 95(6):779-86. PubMed ID: 23172130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Course and treatment of recurrent Hepatitis C after liver transplantation.
    Neumann UP; Neuhaus P
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):61-6. PubMed ID: 15719007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
    Burra P; Rodríguez-Castro KI; Marchini F; Bonfante L; Furian L; Ferrarese A; Zanetto A; Germani G; Russo FP; Senzolo M
    Transpl Int; 2014 Sep; 27(9):877-91. PubMed ID: 24853721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatments for hepatitis.
    Fleming J
    J Infus Nurs; 2002; 25(6):379-82. PubMed ID: 12464795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of hepatitis C in the United States.
    Kim WR
    Hepatology; 2002 Nov; 36(5 Suppl 1):S30-4. PubMed ID: 12407574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis C.
    Sherlock DS
    Dis Mon; 1994 Mar; 40(3):117-96. PubMed ID: 7513276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of HCV-infected pregnant women.
    Valladares G; Chacaltana A; Sjogren MH
    Ann Hepatol; 2010; 9 Suppl():92-7. PubMed ID: 20714003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology Update for the Treatment of Hepatitis C Virus.
    Hopkins L; Dunlap T; Cline H
    Nurs Clin North Am; 2020 Sep; 55(3):347-359. PubMed ID: 32762855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
    Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
    Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Projecting future complications of chronic hepatitis C in the United States.
    Davis GL; Albright JE; Cook SF; Rosenberg DM
    Liver Transpl; 2003 Apr; 9(4):331-8. PubMed ID: 12682882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hepatitis C in patients who have decompensated cirrhosis.
    Everson GT
    Clin Liver Dis; 2005 Aug; 9(3):473-86, viii. PubMed ID: 16023978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of recurrence of hepatitis C infection following liver transplantation.
    Charlton M
    Minerva Chir; 2003 Oct; 58(5):717-24. PubMed ID: 14603150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection: an overview of Wisconsin's public health resources.
    Hurie M; Reiser WJ; Vergeront J
    WMJ; 2006 Jan; 105(1):30-3. PubMed ID: 16676488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.
    Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ
    J Gastroenterol Hepatol; 2014 Aug; 29 Suppl 1():1-9. PubMed ID: 25055928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.